ImmunoPrecise Antibodies Ltd logo

ImmunoPrecise Antibodies Ltd

NEW
NAS:IPA (Canada)  
$ 0.36 +0.020 (+5.85%) 11:08 PM EST
At Loss
P/B:
0.94
Market Cap:
$ 16.47M
Enterprise V:
$ 16.48M
Volume:
446.15K
Avg Vol (2M):
2.57M
Trade In:
What is a stock summary page? Click here for an overview.
Volume:
446.15K
At Loss
Avg Vol (2M):
2.57M

Business Description

Description
ImmunoPrecise Antibodies Ltd is a biotechnology company that leverages multi-omics modeling and complex artificial intelligence through a series proprietary and patented technologies. The company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and are known for solving very complex industry challenges.
Name Current Vs Industry Vs History
Cash-To-Debt 1
Equity-to-Asset 0.55
Debt-to-Equity 0.52
Debt-to-EBITDA -0.28
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -6.13
Distress
Grey
Safe
Beneish M-Score -3.21
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.32
Quick Ratio 2.11
Cash Ratio 1.45
Days Inventory 65.26
Days Sales Outstanding 52.19
Days Payable 147.94

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -12
Shareholder Yield % -70.25

Financials (Next Earnings Date:2025-07-29 Est.)

IPA's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:IPA

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016

ImmunoPrecise Antibodies Ltd Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 17.289
EPS (TTM) ($) -1.16
Beta -0.01
3-Year Sharpe Ratio -1.17
3-Year Sortino Ratio -1.3
Volatility % 47.94
14-Day RSI 43.12
14-Day ATR ($) 0.05592
20-Day SMA ($) 0.400805
12-1 Month Momentum % -75.68
52-Week Range ($) 0.27 - 1.48
Shares Outstanding (Mil) 45.77

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

ImmunoPrecise Antibodies Ltd Filings

Filing Date Document Date Form
No Filing Data

ImmunoPrecise Antibodies Ltd Stock Events

Financials Calendars
Event Date Price ($)
No Event Data

ImmunoPrecise Antibodies Ltd Frequently Asked Questions

What is ImmunoPrecise Antibodies Ltd(IPA)'s stock price today?
The current price of IPA is $0.36. The 52 week high of IPA is $1.48 and 52 week low is $0.27.
When is next earnings date of ImmunoPrecise Antibodies Ltd(IPA)?
The next earnings date of ImmunoPrecise Antibodies Ltd(IPA) is 2025-07-29 Est..
Does ImmunoPrecise Antibodies Ltd(IPA) pay dividends? If so, how much?
ImmunoPrecise Antibodies Ltd(IPA) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1